XTL Biopharmaceuticals Ltd. (XTLB)

XTL Biopharmaceuticals Statistics

Total Valuation

XTLB has a market cap or net worth of $6.87 million. The enterprise value is $6.68 million.

Market Cap	6.87M
Enterprise Value	6.68M

Important Dates

The next estimated earnings date is Thursday, March 12, 2026, before market open.

Earnings Date	Mar 12, 2026
Ex-Dividend Date	n/a

Share Statistics

XTLB has 881.39 million shares outstanding. The number of shares has increased by 54.39% in one year.

Current Share Class	n/a
Shares Outstanding	881.39M
Shares Change (YoY)	+54.39%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	45.39%
Owned by Institutions (%)	2.66%
Float	516.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.10
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.70

Current Ratio	0.70
Quick Ratio	0.46
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-119.78

Financial Efficiency

Return on equity (ROE) is -577.13% and return on invested capital (ROIC) is -329.50%.

Return on Equity (ROE)	-577.13%
Return on Assets (ROA)	-240.56%
Return on Invested Capital (ROIC)	-329.50%
Return on Capital Employed (ROCE)	12,742.55%
Revenue Per Employee	$96,800
Profits Per Employee	-$630,800
Employee Count	10
Asset Turnover	0.62
Inventory Turnover	n/a

Taxes

Income Tax	-349,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.35% in the last 52 weeks. The beta is 0.78, so XTLB's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	-67.35%
50-Day Moving Average	0.87
200-Day Moving Average	1.19
Relative Strength Index (RSI)	37.92
Average Volume (20 Days)	69,403

Short Selling Information

The latest short interest is 12,951, so 0.16% of the outstanding shares have been sold short.

Short Interest	12,951
Short Previous Month	2,238
Short % of Shares Out	0.16%
Short % of Float	n/a
Short Ratio (days to cover)	0.42

Income Statement

In the last 12 months, XTLB had revenue of $968,000 and -$6.31 million in losses. Loss per share was -$0.01.

Revenue	968,000
Gross Profit	-2.25M
Operating Income	-5.99M
Pretax Income	-6.66M
Net Income	-6.31M
EBITDA	n/a
EBIT	-5.99M
Loss Per Share	-$0.01

Balance Sheet

The company has $259,000 in cash and $86,000 in debt, with a net cash position of $173,000 or $0.00 per share.

Cash & Cash Equivalents	259,000
Total Debt	86,000
Net Cash	173,000
Net Cash Per Share	$0.00
Equity (Book Value)	-47,000
Book Value Per Share	-0.00
Working Capital	-228,000

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	-232.85%
Operating Margin	-618.70%
Pretax Margin	-687.71%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XTLB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.39%
Shareholder Yield	-54.39%
Earnings Yield	-91.83%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 10, 2017. It was a reverse split with a ratio of 1:5.

Last Split Date	Feb 10, 2017
Split Type	Reverse
Split Ratio	1:5

Scores

XTLB has an Altman Z-Score of -333.7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-333.7
Piotroski F-Score	n/a